Beyond Air, Inc. Credit Risk Derivative Liabilities, at Fair Value
Beyond Air, Inc. (XAIR) had Credit Risk Derivative Liabilities, at Fair Value of $2.20 million as of 2026-03-31, per its 10-K filed 2026-06-26.
Financial Statements › Notes › Derivative Instruments and Hedging Activities
us-gaap:CreditRiskDerivativeLiabilitiesAtFairValue · last filed 2026-06-26
- 2026-03-31: Credit Risk Derivative Liabilities, at Fair Value $2.20M.
| Period end | Credit Risk Derivative Liabilities, at Fair Value |
|---|---|
| 2026-03-31 | $2.20M 10-K · filed 2026-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |